Ultrasound‐Driven Hollow Nanospheres for Amplified Tumor Oxidative Stress Therapy
Oxidative stress therapy holds great potential owing to its noninvasive nature and high selectivity; however, its efficacy is largely limited by the hypoxic and antioxidative tumor microenvironment (TME). Herein, Ru-doped zinc peroxide (RZO) hollow nanospheres are developed for amplified tumor oxidative stress therapy under US activation. Ru doping optimizes the band structure of ZnO<sub>2</sub> and enhances charge separation efficiency. Under US activation, the piezoelectric polarization of RZO promotes the generation of superoxide (·O<sub>2</sub> <sup>-</sup>) and hydroxyl radicals (·OH), while the in situ-produced H<sub>2</sub>O<sub>2</sub> under mildly acidic conditions facilitates ·OH formation. These synergistic processes induce a cascade of "reactive oxygen species (ROS) storms," leading to mitochondrial damage and apoptosis. In vitro studies demonstrate that RZO-mediated oxidative stress therapy effectively suppresses both 4T1 breast adenocarcinoma and SCC-9 squamous carcinoma cells, while in vivo experiments confirm remarkable tumor inhibition with negligible systemic toxicity. This work proposes a universal and controllable amplification strategy, offering a promising nanoplatform for precise tumor oxidative stress therapy.
Authors
- Lile Dong (ORCID: https://orcid.org/0000-0002-8702-2792)
- Qiurong Sun (ORCID: https://orcid.org/0000-0002-7837-7954)
- Xujian Yang
- Tianhao Ji
- Yan Gong
- Jiarui Wang
Institutions
- University of Science and Technology of China (CN)
- Chinese Academy of Sciences (CN)
- Ganzhou People's Hospital (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
- Changzhou No.2 People's Hospital (CN)
- Huzhou Women and Children's Hospital (CN)
Publication Details
- Journal
- Advanced Healthcare Materials
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1002/adhm.202504973
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67